CompagOS has produced biologically reproducible Bon3OID™ bone models using 3D bioprinting. Find out more in the interview!

Three-dimentional (3D) bioprinting has revolutionized tissue engineering by enabling the in vitro assembly of cells, proteins, and microenvironments into precise 3D biostructures. This technology ...

In a latest review published in Engineering, an international team of scientists from China and the United States has presented a comprehensive analysis of the latest advancements in 3D organ ...

Researching are throwing lots of ideas at the wall to see what sticks, but the U.S. just put some serious cash behind the ...

Carnegie Mellon received $28.5 million to develop liver tissue bioprinting, with hopes it can reduce the need for transplants ...

Taci Pereira, CEO at Systemic Bio, a bioprinting company focused on the development of vascularized organ models used for drug discovery and development. Bioprinting technologies have the potential to ...

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world. Through joint research with ...

Engineers from UNSW Sydney have developed a miniature and flexible soft robotic arm that could be used to 3D-print biomaterial directly onto organs inside a person's body. 3D-bioprinting is a process ...

Delray Beach, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The global 3D bioprinting market, valued at US$1.2 billion in 2023, stood at US$1.3 billion in 2024 and is projected to advance at a resilient CAGR ...